These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 32392604)
1. Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia. Djambas Khayat C; El Khorassani M; Aytaç S; Harroche A; Dahmane A; Pujol S; Henriet C; de Moerloose P; Bridey F Thromb Haemost; 2020 Jun; 120(6):957-967. PubMed ID: 32392604 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency. Djambas Khayat C; El Khorassani M; Lambert T; Gay V; Barthez-Toullec M; Lamazure J; Bellon A; Henriet C; Bridey F; Négrier C J Thromb Haemost; 2019 Apr; 17(4):635-644. PubMed ID: 30661302 [TBL] [Abstract][Full Text] [Related]
3. Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia. Djambas Khayat C; Lohade SD; Zekavat OR; Kruzhkova I; Solomon C; Knaub S; Peyvandi F Haemophilia; 2022 Nov; 28(6):1022-1032. PubMed ID: 35925493 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial. Downey LA; Andrews J; Hedlin H; Kamra K; McKenzie ED; Hanley FL; Williams GD; Guzzetta NA Anesth Analg; 2020 Mar; 130(3):740-751. PubMed ID: 31490252 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. Lissitchkov T; Madan B; Djambas Khayat C; Zozulya N; Ross C; Karimi M; Kavakli K; De Angulo GR; Almomen A; Schwartz BA; Solomon C; Knaub S; Peyvandi F Transfusion; 2018 Feb; 58(2):413-422. PubMed ID: 29194665 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia. Khayat CD; Navarro-Puerto J; Ross CR; Subramanian K; Kalappanavar NK; Rucker K; Liang W; Mondou E Blood Coagul Fibrinolysis; 2023 Jan; 34(1):61-69. PubMed ID: 36484281 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Danés AF; Cuenca LG; Bueno SR; Mendarte Barrenechea L; Ronsano JBM Vox Sang; 2008 Apr; 94(3):221-226. PubMed ID: 18179679 [TBL] [Abstract][Full Text] [Related]
16. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency. Peyvandi F Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654 [TBL] [Abstract][Full Text] [Related]
18. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795 [TBL] [Abstract][Full Text] [Related]
19. Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial. Karkouti K; Callum J; Rao V; Heddle N; Farkouh ME; Crowther MA; Scales DC BMJ Open; 2018 Apr; 8(4):e020741. PubMed ID: 29678987 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Fenger-Eriksen C; Lindberg-Larsen M; Christensen AQ; Ingerslev J; Sørensen B Br J Anaesth; 2008 Dec; 101(6):769-73. PubMed ID: 18818192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]